Employer record · Monroe Township, NJ · FY2025–FY2026

Biozen Therapeutics Inc.

    Certified LCAs
    7
    FY2024–FY2026
    USCIS approvals
    3
    3 new employment
    Denial rate
    0.0%
    FY2024–FY2026
    Median wage offered
    $86k
    certified LCAs

    Jobs not indexed yet

    Does Biozen Therapeutics Inc. sponsor H-1B visas?

    Yes — by its record, Biozen Therapeutics Inc. is a small-scale H-1B sponsor: it filed 7 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 3 USCIS H-1B petition approvals (3 for new employment). Its latest certified LCA in our data was decided Sep 9, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Updated · DOL OFLC LCA disclosure + USCIS H-1B Employer Data Hub

    Filings by fiscal year

    Certified LCAs per U.S. government fiscal year (Oct–Sep); the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.

    Biozen Therapeutics Inc. certified LCAs by fiscal year
    Fiscal yearcertified LCAsUSCIS approvalsApproval rate
    FY2520–
    FY2653100%

    Occupations sponsored

    Occupation (SOC)LCAsMedian wage
    Chemical Engineers 17-20413$86k
    Chemists 19-20313$70k
    Microbiologists 19-10221$63k

    Most-filed job titles

    1. PROCESS ENGINEER4$86k
    2. EXECUTIVE, QUALITY CONTROL MICRO DEPARTMENT1$63k
    3. INNOVATION SCIENTIST, ANALYTICAL RESEARCH AND DEVELOPMENT1$98k
    4. SCIENTIST I - R&D DEPARTMENT1$63k

    LCAs per title and median wage offered.

    Where the jobs were

    1. New Jersey7 LCAs

    We haven't indexed Biozen Therapeutics' jobs yet

    We read jobs straight from employers' own career sites and haven't added Biozen Therapeutics' yet. Its H-1B record on this page comes from public DOL and USCIS data and is not affected.

    Also filed as

    • BIOZEN THERAPEUTICS INC. (LCA)
    • BIOZEN THERAPEUTICS INC (USCIS)

    Biozen Therapeutics Inc. H-1B: questions people ask

    Does Biozen Therapeutics Inc. sponsor H-1B visas?

    Yes — by its record, Biozen Therapeutics Inc. is a small-scale H-1B sponsor: it filed 7 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 3 USCIS H-1B petition approvals (3 for new employment). Its latest certified LCA in our data was decided Sep 9, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Is Biozen Therapeutics Inc. still sponsoring H-1B in 2026?

    Biozen Therapeutics Inc. had 5 certified LCAs in FY2026 (Oct 2025–Sep 2026), more than the 2 in FY2025. The latest one in our data was decided Sep 9, 2026. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.

    How many H-1B petitions does Biozen Therapeutics Inc. get approved?

    USCIS recorded 3 approvals (3 for new employment, the rest continuing employment such as extensions and transfers) and 0 denials for Biozen Therapeutics Inc. in FY2024–FY2026 — a denial rate of 0.0%. Source: USCIS H-1B Employer Data Hub (first decisions).

    What is the H-1B salary at Biozen Therapeutics Inc.?

    The median wage offered on Biozen Therapeutics Inc.'s certified LCAs in FY2024–FY2026 was $86k a year. By job title: PROCESS ENGINEER $86k (4 LCAs), EXECUTIVE, QUALITY CONTROL MICRO DEPARTMENT $63k (1 LCAs) and INNOVATION SCIENTIST, ANALYTICAL RESEARCH AND DEVELOPMENT $98k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.

    Which jobs does Biozen Therapeutics Inc. sponsor for H-1B?

    Its certified LCAs in FY2024–FY2026 were mostly for Chemical Engineers (3), Chemists (3) and Microbiologists (1).

    Where are Biozen Therapeutics Inc.'s H-1B jobs?

    By worksite on its certified LCAs (FY2024–FY2026): New Jersey (7).

    Is Biozen Therapeutics Inc. an H-1B dependent employer?

    No — its recent LCAs do not declare it H-1B dependent.

    Does Biozen Therapeutics Inc. have open jobs?

    We read jobs straight from employers' own career sites and haven't added Biozen Therapeutics' yet.